Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05967273 · ClinicalTrials.gov registry record · NA
CirrhosisRx CDS System
A NA study of Cirrhosis and Decision Support Systems, Clinical, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 2,106
- Enrollment target
- 1
- Study location
NCT05967273 is a NA study of Cirrhosis and Decision Support Systems, Clinical that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 2,106 participants, below the 90,369-participant average among 53 other Cirrhosis trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05967273, a NA study of Cirrhosis and Decision Support Systems, Clinical, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 2,106 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim of the study is to compare the effect of CirrhosisRx, a novel clinical decision support (CDS) system for inpatient cirrhosis care, versus "usual care" on adherence to national quality measures and clinical outcomes for hospitalized patients with cirrhosis.
Conditions Studied
Interventions
- OTHER CirrhosisRx CDS
Study Locations (1)
California
- University of California San Francisco Medical Center - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,106 participants |
| Start Date | 2025-01-14 |
| Est. Completion | 2027-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05967273
The ClinicalTrials.gov registry entry for NCT05967273 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 2,106 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 90,369-participant average among 53 other Cirrhosis trials with a reported enrollment target (98% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cirrhosis appearing as the primary indexed condition, and to 1 intervention - of which CirrhosisRx CDS is the first listed.
NCT05967273 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05967273 about?
NCT05967273 is a clinical study titled "CirrhosisRx CDS System". The aim of the study is to compare the effect of CirrhosisRx, a novel clinical decision support (CDS) system for inpatient cirrhosis care, versus "usual care" on adherence to national quality measures and clinical outcomes for hospitalized patients with cirrhosis.
What is the current status of trial NCT05967273?
This trial is currently recruiting. It is a NA study. The enrollment target is 2,106 participants. The study started on 2025-01-14. Estimated completion is 2027-06.
What conditions does trial NCT05967273 study?
This clinical trial studies the following conditions: Cirrhosis, Decision Support Systems, Clinical.
What interventions are being tested in trial NCT05967273?
The interventions under investigation include: CirrhosisRx CDS (OTHER).
Who is sponsoring clinical trial NCT05967273?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05967273 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cirrhosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
LiverSleep: A Behavioral Sleep Intervention for Patients With Cirrhosis and Insomnia
RECRUITING · NA
-
Copper Supplementation in Cirrhosis
RECRUITING · NA
-
HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
RECRUITING · NA
-
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
RECRUITING · NA
-
Microbiome Modulation With Prebiotics in PTSD and Cirrhosis
RECRUITING · NA
-
Adverse Outcomes and Mortality in Liver Transplant
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.